Tag Archives: Breast Cancer Treatment

AstraZeneca’s Truqap Receives US FDA Approval for Advanced Breast Cancer Treatment

(IN BRIEF) AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has gained approval from the US Food and Drug Administration (FDA) for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer possessing specific … Read the full press release